All In Biotech

Drug Trial Radar · NCT06462235

A Study to Learn About the Study Medicine Aztreonam-Avibactam (ATM-AVI) in Infants and Newborns Admitted in Hospitals With Bacterial Infection (CHERISH)

A PHASE 2A, 2-PART, OPEN-LABEL, NON-RANDOMIZED, MULTICENTER, SINGLE AND MULTIPLE DOSE TRIAL TO EVALUATE PHARMACOKINETICS, SAFETY AND TOLERABILITY OF AZTREONAM AND AVIBACTAM ± METRONIDAZOLE IN NEONATES AND INFANTS FROM BIRTH TO LESS THAN 9 MONTHS OF AGE WITH SUSPECTED OR CONFIRMED INFECTIONS DUE TO GRAM-NEGATIVE PATHOGENS REQUIRING INTRAVENOUS ANTIBIOTIC TREATMENT

Last checked: Nov 20, 2026Latest source record: Nov 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

48

Planned (sponsor's estimate)

Start

Sep 25, 2024

Primary completion

Apr 25, 2027

Study completion Apr 25, 2027

Sponsor

Lead sponsor
PfizerPfizer (PFE)
Sponsor type
Industry
Collaborators
AbbVie
First posted
Jun 17, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Non randomized
Model
Single group
Masking
None
Primary purpose
Basic science
FDA-regulated drug
Yes
Who can join
All sexes, up to 39 weeks
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to learn about the safety and effects of ATM-AVI for the possible treatment of infections caused by a type of bacteria called gram-negative bacteria. The study medicine is a combination of an antibiotic, aztreonam (ATM), and another medicine, avibactam (AVI), which is used to help stop bacteria from being resistant to antibiotics. Antibiotics are medicines that fights bacteria and infections. The study will include newborns and infants up to 9 months of age who are admitted in the hospital. The study is conducted in 2 parts: Part A and Part B. In Part A, all participants will receive a single intravenous (injected directly into a vein) infusion of ATM-AVI. This is to study the safety and effects of a single amount. In Part B, all participants will receive multiple intravenous infusions of ATM-AVI as treatment for a possible or confirmed infection with gram-negative bacteria.

Conditions

  • Gram-negative Bacterial Infection

Interventions

  • Part A: ATM-AVI Single Dose, Cohorts 1-4Drug

    Single intravenous infusion of aztreonam-avibactam over 3 hours to assess pharmacokinetics, safety, and toleration.

  • Part B: Multiple-dose ATM-AVI, Cohorts 1-4Drug

    Multiple intravenous infusions of aztreonam-avibactam over 3 hours, repeated every 6-8 hours up to 14 days to assess pharmacokinetics, safety, toleration, and efficacy.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Maximum Predicted Plasma Concentration (Cmax) of ATM and AVITime frame: Up to Day 15
  2. Area under the Concentration-Time Curve (AUC) of ATM-AVITime frame: Up to Day 15
  3. Plasma Elimination Half-Life (t1/2)Time frame: Up to Day 15
  4. Apparent Clearance (CL)Time frame: Up to Day 15
  5. Plasma concentrations of ATM and AVI by nominal sampling timeTime frame: Up to Day 15
  6. Proportion of Participants reporting Adverse Events (AE)Time frame: Baseline up to Day 50
  7. Proportion of Participants reporting Serious Adverse Events (SAE)Time frame: Baseline up to Day 50
  8. Proportion of Participants reporting AEs leading to discontinuation of study drugTime frame: Baseline up to Day 50
  9. Proportion of Participants reporting AEs resulting in deathTime frame: Baseline up to Day 50
  10. Proportion of Participants reporting liver injury and acute kidney injuryTime frame: Baseline up to Day 50

Locations

36 sites in 10 countries. Site status is shown where the registry gives one.

  • Children's Hospital of Orange County Southwest Tower

    Orange, California · Recruiting

  • Children's Hospital of Orange County

    Orange, California · Recruiting

  • Children's Hospital Colorado

    Aurora, Colorado · Recruiting

  • Riley Hospital for Children at Indiana University Health

    Indianapolis, Indiana · Recruiting

  • Norton Children's Hospital

    Louisville, Kentucky · Recruiting

  • Novak Center for Children's Health

    Louisville, Kentucky · Recruiting

  • University of Louisville, Norton Children's Research Institute

    Louisville, Kentucky · Recruiting

  • Tufts Medical Center

    Boston, Massachusetts · Recruiting

  • Duke University - Main Hospital and Clinics

    Durham, North Carolina · Recruiting

  • Memorial Hermann Hospital - Texas Medical Center

    Houston, Texas · Recruiting

  • The University of Texas Health Science Center at Houston

    Houston, Texas · Recruiting

  • Sanatorio Sagrado Corazón

    Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina · Recruiting

  • Clinica Del Niño Y La Madre

    Mar del Plata, Buenos Aires, Argentina · Recruiting

  • Clinica Privada del Sol S.A

    Córdoba, Córdoba Province, Argentina · Recruiting

  • Hospital del Niño Jesús

    San Miguel de Tucumán, Tucumán Province, Argentina · Recruiting

  • UMHAT Deva Maria

    Burgas, Bulgaria · Recruiting

  • Umhat Kanev

    Rousse, Bulgaria · Recruiting

  • Acibadem City Clinic University Multiprofile Hospital for Active Treatment Tokuda EAD

    Sofia, Bulgaria · Recruiting

  • University General Hospital of Heraklion

    Heraklion, Irakleío, Greece · Recruiting

  • Ippokrateio General Hospital of Thessaloniki

    Thessaloniki, Kentrikí Makedonía, Greece · Recruiting

  • Nirmal Hospital Pvt Ltd.

    Surat, Gujarat, India · Recruiting

  • RajaRajeswari Medical College and Hospital

    Bengaluru, Karnataka, India · Recruiting

  • Sahyadri Super Speciality Hospital

    Pune, Maharashtra, India · Recruiting

  • Medanta Hospital Lucknow

    Lucknow, Uttar Pradesh, India · Recruiting

  • Institute of Child Health

    Kolkata, West Bengal, India · Recruiting

  • Schneider Children's Medical Center

    Petah Tikva, Central District, Israel · Recruiting

  • Rambam Health Care Campus

    Haifa, Northern District, Israel · Recruiting

  • Azienda Ospedaliera Universitaria Meyer IRCCS

    Florence, Florence, Italy · Recruiting

  • Hospital Civil Fray Antonio Alcalde

    Guadalajara, Jalisco, Mexico · Not yet recruiting

  • Hospital Universitario 12 de Octubre

    Madrid, Spain · Not yet recruiting

  • Hospital Sant Joan de Déu

    Esplugues de Llobregat, Barcelona [barcelona], Spain · Recruiting

  • Hospital Universitario La Paz

    Madrid, Madrid, Comunidad de, Spain · Recruiting

  • Taichung Veterans General Hospital

    Taichung, Taiwan · Recruiting

  • Chang Gung Medical Foundation Linkou Chang Gung Memorial Hospital

    Taoyuan, Taiwan · Recruiting

  • Hsinchu Municipal Mackay Children's Hospital

    Hsinchu, Hsinchu, Taiwan · Recruiting

  • Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation

    Hualien City, Hualien, Taiwan · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.